Skip to main content

Table 2 Last Lipid Panel Results Prior to Any Microvascular Event or Censorship

From: The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus

Lipid Characteristics All Patients Event1 No Event2 P- Value3
N = 72,267 n = 7,271 n = 64,996
# Days from Last Lipid Panel to Any Microvascular Event/Censorship: mean ± SD 346.21 ±351.43 148.40 ±223.94 368.34 ±356.15 <.0001
Lipid Panel Values: mean ± SD
LDL-C 109.08 ±34.35 108.33 ±36.47 109.16 ±34.1 .0513
HDL-C 48.02 ±14.13 46.72 ±14.04 48.16 ±14.13 <.0001
Triglycerides 163.35 ±122 186.39 ±186.41 160.77 ±112.23 <.0001
Non-HDL-C 140.55 ±40.25 143.19 ±45.9 140.26 ±39.56 <.0001
Lipid Goal Attainment Results: n, row%
LDL-C 30,395 42.06 % 3,185 43.80 % 27,210 41.86 % .0015
HDL-C 37,946 52.51 % 3,527 48.51 % 34,419 52.96 % <.0001
Triglycerides 43,577 60.30 % 3,948 54.30 % 39,629 60.97 % <.0001
Non-HDL-C 30,737 42.53 % 3,032 41.70 % 27,705 42.63 % .1299
  1. 1For those patients who experienced any corresponding microvascular event of interest (diabetic retinopathy/nephropathy/neuropathy), mean values of the last laboratory assessment prior to the first event are presented.
  2. 2For those patients who did not experience the microvascular event of interest (diabetic retinopathy/nephropathy/neuropathy), mean values of the last laboratory assessment prior to censorship (death, age >64 years, end of plan eligibility, or data period) are presented.
  3. 3P-value between the event and no event groups is significant at < .05.
  4. LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides.